Pharma

Facebook Timequake Coming for Pharma 3/30!

March 22, 2012

If you have any doubts on who is in charge of calling the shots on Social Media, stop wondering. It’s Facebook, by size and impact. The platform is in control and the timelines to adapt to change are shortening. Facebook rolled out Timeline to brands on 2/29 and all brand pages will be forced to [...]

Read the full article →

End of the Year Surprise: FDA Draft Guidance for Off-Label Information

January 5, 2012

Over the holidays, and without fanfare, the FDA issued Draft Guidance for Responding to Unsolicited Requests for Off-Label Information. The title of the guidance is a little deceptive in that within the document lies some draft guidance on dealing with social media in the form of ‘public’ platforms where some of this conversation may take [...]

Read the full article →

Facebook Pharma Earthquake!

August 10, 2011

Facebook has rocked the pharma world with its announcement that pharma ‘whitelisting’ will largely disappear on August 15th. Whitelisting has been a special exemption where pharma has been able to prevent people from being able to Like or comment on their Wall posts. So we might actually have to engage with people rather than broadcasting. [...]

Read the full article →

Blogger Outreach, PR and Healthcare

April 20, 2011

This story originally appeared in PRWeek Insider on 04/20/11 (subscription required). With the emergence of today’s digital space, it is safe to say that bloggers are the new reporters and journalists. Their content reaches many at once and is easily accessible by a click of the finger. What bloggers choose to feature on and write [...]

Read the full article →